Table 1.
A. Phenotypic spectrum | |
---|---|
Localised or tissue-specific, MIM | Multisystemic and with possible brain involvement, MIM |
Macrodactyly, #155500 | Fibroadipose Overgrowth/Hemihyperplasia-Multiple Lipomatosis (FAO/HHML) |
Epidermal Nevi, #162900 | Congenital Lipomatous Overgrowth, Vascular Malformations, Epidermal Nevi, Scoliosis/Skeletal and Spinal Abnormalities syndrome (CLOVES), #612918 |
Seborrheic Keratosis, #182000 | Capillary malformation of the lower lip, Lymphatic malformation of face and neck, Asymmetry of face and limbs, and Partial/generalized Overgrowth syndrome (CLAPO), #613089 |
PIK3CA-related muscular overgrowth with ectopic accessory muscles (Al-Qattan et al., 2018). | Megalencephaly-Capillary Malformation-Polymicrogyria syndrome (MCAP), #602501 |
Hemiorofacial asymmetry with peripheral nerve enlargement andperineuriomatous pseudo-onion bulb proliferations (Koutlas et al., 2021) | |
Facial infiltrating lipomatosis (FIL) (Couto et al., 2017) | |
Lymphatic malformations (LM) (Zenner et al., 2019) | |
Klippel-Trenaunay syndrome (KTS), %149000 | |
B. Management* | |
MCAP | Non-MCAP PROS |
Activating, mosaic PIK3CA variant | Activating, mosaic PIK3CAvariant |
Meg and/or PMG | No significant Meg or PMG or Sx |
Extra-CNS overgrowth and/or vasc findings | Extra-CNS overgrowth and vasc findings |
rare PROS individuals have been reported with consitutional variants (De Graer et al., 2020)
Meg: Megalencephaly (see Appendix), PMG: Polymicrogyria, Sx: syrinx, CNS: Central Nervous System, vasc: vascular including cutaneous